Human T-cell leukemia virus type II directly acts on CD34+ hematopoietic precursors by increasing their survival potential. Envelope-associated HLA class II molecules reverse this effect

Blood

Volumn 91, Issue 7, 1998, Pages 2296-2304

  Casoli, Claudio ^a   Re, Maria Carla ^b   Monari, Paola ^b   Furlini, Giuliano ^b   Tosi, Giovanna ^b   Gradozzi, Chiara ^b   Dall'Aglio, Pier Paolo ^b   Bertazzoni, Umberto ^b   Accolla, Roberto S ^b  

^a UNIVERSITY OF PARMA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; HLA ANTIGEN CLASS 2; INTERLEUKIN 3;

APOPTOSIS; ARTICLE; CELL SURVIVAL; CLINICAL ARTICLE; HEMATOLOGIC DISEASE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 2; LYMPHOPROLIFERATIVE DISEASE; PRIORITY JOURNAL; VIRUS CELL INTERACTION; VIRUS STRAIN;

EID: 0032055516     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.7.2296.2296_2296_2304     Document Type: Article

References (42)

1. Mams A, Blattner WA: The epidemiology of the human T cell lymphotropic virus type I and II: Etiologic role in human disease. Transfusion 31:67, 1991
2. Hall WW, Takayuki K, Ijichi S, Takahashi H, Zhu SW: Human T cell leukemia/lymphoma virus, type II (HTLV-II): Emergence of an important newly recognized pathogen. Semin Virol 5:165, 1994
3. Green PL, Chen YSY: Regulation of human T cell leukemia virus expression. FASEB J 4:169, 1990
4. Smith MR, Greene WC: Molecular biology of the type I human T-cell leukemia virus (HTLV-I) and adult T-cell leukemia. J Clin Invest 87:761, 1991
5. Coates SR, Harris AJ, Parkes DL, Smith CM, Liu HLC, Akita RW, Ferrer MM, Sampson EK, Brandis JW, Sliwkowski MX: Serological evaluation of Escherichia coli-expressed human T-cell leukemia virus type I env, gag p24, and tax proteins. J Clin Microbiol 28:1139, 1990
6. Kashiwagi S, Kajiyama W, Hayashi J, Noguchi A, Nakashima K, Nomura H, Ikematsu H, Sawada T, Kida S, Koide A: Antibody to p40tax protein of human T cell leukemia virus I and infectivity. J Infect Dis 161:426, 1990
7. + cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature 348:245, 1990
8. Lindholm PF, Marriot SJ, Gitlin SD, Bohan CA, Brady JN: Induction of nuclear NF-B DNA binding activity after exposure of lymphoid cells to soluble Tax 1 protein. New Biol 2:1034, 1990
9. Arthur LO, Bess JW Jr, Sowder RC II, Benveniste RE, Mann DL, Chermann J-C, Henderson LE: Cellular proteins bound to immunodeficiency viruses: Implication for pathogenesis. Science 258:1935, 1992
10. Koyanagi Y, Itoyama Y, Nakamura N, Takamatsu K, Kira J, Iwamasa T, Goto I, Yamamoto N: In vivo infection of human T-cell leukemia virus type I in non-T cells. Virology 196:25, 1993
11. Casoli C, Cimarelli A, Bertazzoni U: Cellular tropism of human T-cell leukemia virus type II is enlarged to B lymphocytes in patients with high proviral load. Virology 206:1126, 1995
12. + cells. Virology 210:441, 1995
13. Nagafuji K, Harada M, Teshima T, Eto T, Takamatsu Y, Okamura T, Murakawa M, Akashi K, Niho Y: Hematopoietic progenitor cells from patients with adult T-cell leukemia-lymphoma are not infected with human T-cell leukemia virus type I. Blood 82:2823, 1993
14. Crompton T: IL-3 dependent cells die by apoptosis on removal of their growth factor. Growth Factors 4:109, 1991
15. Baffy G, Miyashita T, Williamson JR, Reed JC: Apoptosis induced by withdrawal of interleukin-3 (IL-3) from an IL-3-dependent hematopoietic cell line is associated with repartitioning of intracellular calcium and is blocked by enforced bcl-2 oncoprotein production. J Biol Chem 268:6511, 1993
16. Meyaard L, Otto SA, Jonker RR, Mijnster MJ, Keet RPM, Miedema F: Programmed death of T-cells in HIV-1 infection. Science 257:217, 1992
17. + T lymphocytes in Epstein-Barr virus induced infectious mononucleosis. Blood 80:452, 1992
18. Henderson S, Rowe M, Gregory C, Croom-Carter D, Wang F, Longnecker R, Kieff E, Rickinson A: Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 65:1107, 1991
19. Levine B, Huang Q, Isaacs JY, Reed JC, Griffith DE, Hardwick JM: Conversion of lytic to persistent alphavirus infection by the bcl-2 cellular oncogene. Nature 361:739, 1993
20. Salemi M, Vandamme AM, Guano F, Gradozzi C, Cattaneo E, Casoli C, Bertazzoni U: Complete nucleotide sequence of the Italian human T-cell lymphotropic virus type II isolate Gu and phylogenetic identification of a possible origin of south European epidemics. J Gen Virol 77:1193, 1996
21. Kitamura T, Tange T, Terasawa T, Chiba S, Kuwaki T, Miyagawa K, Piao YF, Urabe A, Tukaku F: Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3 or erythropoietin. J Cell Physiol 140:323, 1989
22. Chen ISY, McLaughlin J, Gasson JC, Clarck SC, Golde DW: Molecular characterization of genome of a novel human T-cell leukemia virus. Nature 305:502, 1983
23. Zella D, Cavicchini A, Salemi M, Casoli C, Lori F, Achilli G, Cattaneo E, Landini V, Bertazzoni U: Molecular characterization of two isolates of human T-cell leukemia virus type II from Italian drug abusers and comparison of genome structure with other isolates. J Gen Virol 74:437, 1993
24. +) cells purified from the bone marrow of AIDS patients are committed to apoptotic cell death in culture. AIDS 7:1049, 1993
25. Facchinetti A, Tessarollo L, Mazzocchi M, Kingston R, Collavo D, Biasi G: An improved method for detection of DNA fragmentation. J Immunol Methods 136:125, 1991
26. Lemonnier FA, Rebaj N, Le Bouteiller PP, Malissen B, Caillol DH, Kourilsky PM: Epitopic analysis of detergent-solubilized HLA molecules by solid-phase radioimmunoassay. J Immunol Methods 54:9, 1982
27. Ziegler A, Gotz H, Heinig J, Muller C, Thinnes FP, UchanskaZiegker B, Werner P: Analysis of sequential immunoprecipitations of the specificities of the monoclonal antibodies Tu22, 34, 35, 36, 37, 39, 43, 58, and Yd1/63.HLK directed against human HLA class II antigens. Immunobiology 171:77, 1986
28. Accolla RS, Gross N, Carrel S, Corte G: Distinct forms of both α and β subunits are present in the human Ia molecular pool. Proc Natl Acad Sci USA 78:4549, 1981
29. Gazzolo L, Duc Dodon M: Human T-lymphotropic virus type 1 is a direct activator of resting T lymphocytes. Nature 326:714, 1987
30. Cassé H, Girerd Y, Gazzolo L, Duc Dodon M: Critical involvement of human T cell leukemia virus type I virions in mediating the viral mitogenic effect. J Gen Virol 75:1909, 1994
31. Lindholm PF, Reid RL, Brady JN: Extracellular Tax1 protein stimulates tumor necrosis factor-β and immunoglobulin kappa light chain expression in lymphoid cells. J Virol 66:1294, 1992
32. Marriot SJ, Trinh D, Brady JN: Activation of interleukin-2 receptor alpha expression by extracellular HTLV-I Tax 1 protein: A potential role in HTLV-I pathogenesis. Oncogene 7:1749, 1992
33. Martin TC, Southern PJ: Infection and cellular activation by human T-cell leukemia viruses, types I and II. Virology 221:375, 1996
34. Harrowe G, Cheng-Mayer C: Amino acid substitutions in the V3 loop are responsible for adaptation to growth in transformed T-cell lines of a primary human immunodeficiency virus type 1. Virology 210:490, 1995
35. Benkirane M, Blanc-Zouaoui D, Hirn M, Devaux C: Involvement of human leukocyte antigen class I molecules in human immunodeficiency virus infection of CD4-positive cells. J Virol 68:6332, 1994
36. Briant L, Benkirane M, Girard M, Hirn M, Iosef C, Devaux C: Inhibition of human immunodeficiency virus type 1 production in infected peripheral blood mononuclear cells by human leukocyte antigen class I-specific antibodies: Evidence for a novel antiviral mechanism. J Virol 70:5213, 1996
37. Rossio JL, Bess J Jr, Henderson LE, Cresswell P, Arthur LO: HLA class II on HIV particles is functional in superantigen presentation to human T cells: Implication for HIV pathogenesis. AIDS Res Hum Retroviruses 11.1433, 1995
38. Akari H, Goto Y, Shinjo T: Detection of the cellular membrane proteins of human T cell leukemia virus type I. Arch Virol 140:375, 1995
39. Accolla RS, Adorini L, Sartoris S, Sinigaglia F, Guardiola J: MHC: Orchestrating the immune response. Immunol Today 16:8, 1995
40. Lenschow DJ, Walunas TL, Bluestone JA: CD28/B7 system of T cell costimulation. Annu Rev Immunol 14:233, 1996
41. Yoshino T, Cao L, Nishiuchi R, Matsuo Y, Yamadori I, Kondo E, Teramoto N, Hayashi K, Takahashi K, Kamikawaj N: Ligation of HLA class II molecules promotes sensitivity to CD95 (Fas antigen, APO-1)-mediated apoptosis. Eur J Immunol 25:2190, 1995
42. Truman JP, Ericson ML, Choqueux-Seebold CJ, Charron DJ, Mooney NA: Lymphocyte programmed cell death is mediated via HLA class II DR. Int Immunol 6:887, 1994